aspirin has been researched along with Infections, Coronavirus in 21 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Excerpt | Relevance | Reference |
---|---|---|
"Both hypoxemia and a prothrombotic diathesis have been associated with more severe disease and increased risk of death." | 2.94 | Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study. ( Forleo, GB; Radovanovic, D; Santus, P; Viecca, M, 2020) |
"Indeed, Kawasaki disease is induced by overreaction of innate cells following exposition to various viruses, including herpes viruses which trigger STING." | 2.66 | Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway? ( Berthelot, JM; Drouet, L; Lioté, F, 2020) |
" Hence, whether ASA might be a safe and reasonable therapeutic candidate to be tested in clinical trials involving adults with COVID-19 deserves further attention." | 2.66 | Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ? ( Bianconi, V; Fallarino, F; Pignatelli, P; Pirro, M; Sahebkar, A; Violi, F, 2020) |
"BACKGROUND Coronavirus disease 2019 (COVID-19) infection commonly presents as fever, cough, and shortness of breath in adults." | 1.56 | Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2. ( Bauerfeld, C; Garcia, RU; Heidemann, SM; Martin, A; Sarnaik, AP; Tilford, B; Yagiela, L, 2020) |
"In patients with STEMI, fibrinolysis achieved a comparable in-hospital and 30-day primary composite end point, as compared with those who received PPCI during the COVID-19 pandemic." | 1.56 | Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic. ( Huang, Z; Lin, Y; Su, H; Wang, N; Zhang, M, 2020) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (4.76) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 20 (95.24) | 2.80 |
Authors | Studies |
---|---|
Kwiatkowski, S | 1 |
Borowski, D | 1 |
Kajdy, A | 1 |
Poon, LC | 1 |
Rokita, W | 1 |
Wielgos, M | 1 |
Gavillet, M | 1 |
Rolnik, DL | 1 |
Hoffman, MK | 1 |
Panchaud, A | 1 |
Baud, D | 1 |
Viecca, M | 1 |
Radovanovic, D | 1 |
Forleo, GB | 1 |
Santus, P | 1 |
Rauf, A | 1 |
Vijayan, A | 1 |
John, ST | 1 |
Krishnan, R | 1 |
Latheef, A | 1 |
Gurbel, PA | 1 |
Bliden, KP | 1 |
Schrör, K | 1 |
Alay, H | 1 |
Can, FK | 1 |
Gözgeç, E | 1 |
Berthelot, JM | 1 |
Drouet, L | 1 |
Lioté, F | 1 |
Bianconi, V | 1 |
Violi, F | 1 |
Fallarino, F | 1 |
Pignatelli, P | 1 |
Sahebkar, A | 1 |
Pirro, M | 1 |
Lal, S | 1 |
Hashmi, J | 1 |
Heidemann, SM | 1 |
Tilford, B | 1 |
Bauerfeld, C | 1 |
Martin, A | 1 |
Garcia, RU | 1 |
Yagiela, L | 1 |
Sarnaik, AP | 1 |
Lee, WS | 1 |
Margolskee, E | 1 |
Mattioli, M | 1 |
Benfaremo, D | 1 |
Fustini, E | 1 |
Gennarini, S | 1 |
Trifan, G | 1 |
Hillmann, M | 1 |
Testai, FD | 1 |
Florêncio, FKZ | 1 |
Tenório, MO | 1 |
Macedo Júnior, ARA | 1 |
Lima, SG | 1 |
Kofman, AD | 1 |
Sizemore, EK | 1 |
Detelich, JF | 1 |
Albrecht, B | 1 |
Piantadosi, AL | 1 |
Haque, S | 1 |
Jawed, A | 1 |
Akhter, N | 1 |
Dar, SA | 1 |
Khan, F | 1 |
Mandal, RK | 1 |
Areeshi, MY | 1 |
Lohani, M | 1 |
Wahid, M | 1 |
Wang, N | 1 |
Zhang, M | 2 |
Su, H | 1 |
Huang, Z | 1 |
Lin, Y | 1 |
Ghati, N | 1 |
Roy, A | 1 |
Bhatnagar, S | 1 |
Bhati, S | 1 |
Bhushan, S | 1 |
Mahendran, M | 1 |
Thakur, A | 1 |
Tiwari, P | 1 |
Dwivedi, T | 1 |
Mani, K | 1 |
Gupta, R | 1 |
Mohan, A | 1 |
Garg, R | 1 |
Saxena, A | 1 |
Guleria, R | 1 |
Deepti, S | 1 |
Yang, Y | 1 |
Qidwai, U | 1 |
Burton, BJL | 1 |
Canepa, C | 1 |
Itsekson Hayosh, Z | 1 |
Schwammenthal, Y | 1 |
Orion, D | 1 |
Amici, C | 1 |
Di Caro, A | 1 |
Ciucci, A | 1 |
Chiappa, L | 1 |
Castilletti, C | 1 |
Martella, V | 1 |
Decaro, N | 1 |
Buonavoglia, C | 1 |
Capobianchi, MR | 1 |
Santoro, MG | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Dynamics of Hemostatic Parameters in COVID-19 and Comparison of Intervention Strategies Through Adaptive Clinical Trial[NCT04466670] | Phase 2 | 379 participants (Anticipated) | Interventional | 2020-07-11 | Recruiting | ||
Multicenter Randomized, Double-blind, Placebo-controlled, Clinical Trial of Acetylsalicylic Acid in the Prevention of Severe SARS-CoV2 Pneumonia in Hospitalised Patients (Asperum)[NCT04808895] | Phase 3 | 204 participants (Anticipated) | Interventional | 2021-04-01 | Not yet recruiting | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
3 reviews available for aspirin and Infections, Coronavirus
Article | Year |
---|---|
Can an Old Ally Defeat a New Enemy?
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Betacoronavirus; Coronavirus Infections; | 2020 |
Kawasaki-like diseases and thrombotic coagulopathy in COVID-19: delayed over-activation of the STING pathway?
Topics: Angiotensin II; Animals; Aspirin; Blood Coagulation Disorders; Coronavirus Infections; COVID-19; Dip | 2020 |
Is Acetylsalicylic Acid a Safe and Potentially Useful Choice for Adult Patients with COVID-19 ?
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID | 2020 |
3 trials available for aspirin and Infections, Coronavirus
Article | Year |
---|---|
Enhanced platelet inhibition treatment improves hypoxemia in patients with severe Covid-19 and hypercoagulability. A case control, proof of concept study.
Topics: Aged; Aspirin; Betacoronavirus; Clopidogrel; Compassionate Use Trials; Coronavirus Infections; COVID | 2020 |
Atorvastatin and Aspirin as Adjuvant Therapy in Patients with SARS-CoV-2 Infection: A structured summary of a study protocol for a randomised controlled trial.
Topics: Adult; Aged; Aspirin; Atorvastatin; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug | 2020 |
Indomethacin has a potent antiviral activity against SARS coronavirus.
Topics: Animals; Antiviral Agents; Aspirin; Cell Line; Chlorocebus aethiops; Coronavirus Infections; Coronav | 2006 |
15 other studies available for aspirin and Infections, Coronavirus
Article | Year |
---|---|
Why we should not stop giving aspirin to pregnant women during the COVID-19 pandemic.
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Infant; Infant, Newborn; | 2020 |
Should we stop aspirin prophylaxis in pregnant women diagnosed with COVID-19?
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Female; Humans; Pandemics; Pneumonia, Vi | 2020 |
Multisystem Inflammatory Syndrome with Features of Atypical Kawasaki Disease during COVID-19 Pandemic.
Topics: Aspirin; Child, Preschool; Coronavirus Infections; COVID-19; Diagnosis, Differential; Humans; Immuno | 2020 |
Cerebral Infarction in an Elderly Patient with Coronavirus Disease.
Topics: Aged, 80 and over; Anticoagulants; Aspirin; Betacoronavirus; Cerebral Infarction; Coronavirus; Coron | 2020 |
A Rare Finding of Upper Limb Deep Venous Thrombosis in a Patient with COVID-19.
Topics: Anticoagulants; Arm; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Edema; Enoxaparin; | 2020 |
Three Cases of Pediatric Multisystem Inflammatory Syndrome Associated with COVID-19 Due to SARS-CoV-2.
Topics: Antipyretics; Aspirin; Betacoronavirus; Child; Child, Preschool; Conjunctivitis; Coronavirus Infecti | 2020 |
Leukoerythroblastosis and plasmacytoid lymphocytes in a child with SARS-CoV-2-associated multisystem inflammatory syndrome.
Topics: Anti-Inflammatory Agents; Aspirin; Betacoronavirus; Child; Clinical Laboratory Techniques; Coronavir | 2020 |
Atypical Spontaneous Hematomas in a Patient with Severe Coronavirus Disease 2019 (COVID-19).
Topics: Aged, 80 and over; Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Erythrocyte Transfusi | 2020 |
Acute Stroke as the Presenting Symptom of SARS-CoV-2 Infection in a Young Patient with Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy.
Topics: Adult; Aspirin; Betacoronavirus; CADASIL; Coronavirus Infections; COVID-19; Female; Host-Pathogen In | 2020 |
Aspirin with or without statin in the treatment of endotheliitis, thrombosis, and ischemia in coronavirus disease.
Topics: Aspirin; Betacoronavirus; Comorbidity; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; En | 2020 |
A young adult with COVID-19 and multisystem inflammatory syndrome in children (MIS-C)-like illness: a case report.
Topics: Adult; Aspirin; Betacoronavirus; Coronavirus Infections; Cough; COVID-19; COVID-19 Drug Treatment; D | 2020 |
Acetylsalicylic acid (Aspirin): a potent medicine for preventing COVID-19 deaths caused by thrombosis and pulmonary embolism.
Topics: Aspirin; Betacoronavirus; Coronavirus Infections; COVID-19; Humans; Pandemics; Platelet Aggregation | 2020 |
Fibrinolysis is a reasonable alternative for STEMI care during the COVID-19 pandemic.
Topics: Aged; Aspirin; Clopidogrel; Coronavirus Infections; COVID-19; Female; Fibrinolysis; Fibrinolytic Age | 2020 |
Bilateral, vertical supranuclear gaze palsy following unilateral midbrain infarct.
Topics: Aspirin; Atrial Fibrillation; Betacoronavirus; Blindness; Brain Stem Infarctions; Coronavirus Infect | 2020 |
Can other coronavirus infections cause a cryptogenic stroke in a young patient?
Topics: Acyclovir; Antiviral Agents; Aspirin; Coronavirus Infections; Coronavirus OC43, Human; COVID-19; Hum | 2021 |